Close Menu

Waters

NEW YORK (GenomeWeb) – Investment bank Stifel this week initiated coverage of four life science tools firms operating in the omics market and said that, overall, the space is poised for growth in the coming years as major end markets have stabilized and are improving for the first time in years.

NEW YORK (GenomeWeb) – Life sciences mass spec turned in a strong second quarter, even as the larger fortunes of individual vendors varied.

NEW YORK (GenomeWeb) – Waters paid $23 million in cash for the net assets of MediMass, the firm said in a document filed with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb) – With the launch last year of two US Food and Drug Administration-cleared mass spec microbiology platforms, microbe identification has emerged as one of clinical proteomics' most prominent success stories.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the second quarter were up 7 percent, driven by broad-based pharmaceutical demand and strong US sales.

NEW YORK (GenomeWeb) – Waters today announced that it will establish a joint open laboratory with the Chinese Pharmacopoeia Commission.

NEW YORK (GenomeWeb News) – Waters has sold $200 million in senior notes in a private placement, it said in a filing with the US Securities and Exchange Commission today.

BALTIMORE (GenomeWeb News) – While triple quads predominated at last year's American Society for Mass Spectrometry annual meeting, high-resolution instruments were the focus of this year's gathering with several vendors launching new high-end QTOF or Q-Orbitrap machines.

BALTIMORE (GenomeWeb) – With the launch of a new crop of high-resolution instruments at the American Society for Mass Spectrometry annual conference here this week, vendor

New Products: ASMS Focus

Premium

A number of vendors introduced new proteomics products at the American Society for Mass Spectrometry meeting in Baltimore this week. The following is a roundup of new offerings introduced at the conference.

Pages

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.